CYP 1.82% 27.0¢ cynata therapeutics limited

Going forward..., page-67

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    could it be the BOD offloading their newly acquired free shares? or are they still waiting for them to be issued? Furthermore, the info coming out of Japan is a little market sensitive. I mean, how can fuji start sprouting they are going to trial with a product they currently don't own or have access to? that obviously implies they are going to acquire it, and yet the market does not care.
    Without any competitive tension, no need for them to spend anymore than the required 3M and gain access to GVHD, de risk it further in their own trials and probably buy CYP later next year for the same price.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.